NIH launches study of third COVID-19 vaccine dose in kidney transplant recipients
The trial will assess antibody response in people who did not respond to two-dose regimen
Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Browsing Tag
National Institute of Allergy and Infectious Diseases
Zydus to tie up with US-based research centre
To develop a vaccine against visceral leishmaniasis
Zydus to tie up with US-based research centre to develop vaccine
Etna Biotech will also donate $2,40,000 for advancing research under the NIH leishmaniasis programme